Mapping brain morphology to cognitive deficits: a study on PD-CRS scores in Parkinson's disease with mild cognitive impairment.
Autor: | Brandão PR; Neuroscience and Behavior Lab, Biological Sciences Institute, University of Brasília (UnB), Brasília, Brazil.; Hospital Sírio-Libanês, Instituto de Ensino e Pesquisa, Brasília, Brazil., Pereira DA; Brazilian Institute of Neuropsychology and Cognitive Sciences (IBNeuro), Brasília, Brazil., Grippe TC; Movement Disorders Centre, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada., Bispo DDC; Radiology Department, Brasilia University Hospital (HUB-UnB), University of Brasília (UnB), Brasília, Brazil.; Radiology Department, Santa Marta Hospital, Taguatinga, Brazil., Maluf FB; Radiology Department, Santa Marta Hospital, Taguatinga, Brazil., Titze-de-Almeida R; Central Institute of Sciences, Research Center for Major Themes - Neurodegenerative disorders, University of Brasília, Brasília, Brazil., de Almeida E Castro BM; Neuroscience and Behavior Lab, Biological Sciences Institute, University of Brasília (UnB), Brasília, Brazil.; Hospital Sírio-Libanês, Instituto de Ensino e Pesquisa, Brasília, Brazil., Munhoz RP; Movement Disorders Centre, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada., Tavares MCH; Neuroscience and Behavior Lab, Biological Sciences Institute, University of Brasília (UnB), Brasília, Brazil., Cardoso F; Internal Medicine, Neurology Service, Movement Disorder Centre, The Federal University of Minas Gerais, Belo Horizonte, Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in neuroanatomy [Front Neuroanat] 2024 Aug 14; Vol. 18, pp. 1362165. Date of Electronic Publication: 2024 Aug 14 (Print Publication: 2024). |
DOI: | 10.3389/fnana.2024.1362165 |
Abstrakt: | Background: The Parkinson's Disease-Cognitive Rating Scale (PD-CRS) is a widely used tool for detecting mild cognitive impairment (MCI) in Parkinson's Disease (PD) patients, however, the neuroanatomical underpinnings of this test's outcomes require clarification. This study aims to: (a) investigate cortical volume (CVol) and cortical thickness (CTh) disparities between PD patients exhibiting mild cognitive impairment (PD-MCI) and those with preserved cognitive abilities (PD-IC); and (b) identify the structural correlates in magnetic resonance imaging (MRI) of overall PD-CRS performance, including its subtest scores, within a non-demented PD cohort. Materials and Methods: This study involved 51 PD patients with Hoehn & Yahr stages I-II, categorized into two groups: PD-IC ( n = 36) and PD-MCI ( n = 15). Cognitive screening evaluations utilized the PD-CRS and the Montreal Cognitive Assessment (MoCA). PD-MCI classification adhered to the Movement Disorder Society Task Force criteria, incorporating extensive neuropsychological assessments. The interrelation between brain morphology and cognitive performance was determined using FreeSurfer. Results: Vertex-wise analysis of the entire brain demonstrated a notable reduction in CVol within a 2,934 mm 2 cluster, encompassing parietal and temporal regions, in the PD-MCI group relative to the PD-IC group. Lower PD-CRS total scores correlated with decreased CVol in the middle frontal, superior temporal, inferior parietal, and cingulate cortices. The PD-CRS subtests for Sustained Attention and Clock Drawing were associated with cortical thinning in distinct regions: the Clock Drawing subtest correlated with changes in the parietal lobe, insula, and superior temporal cortex morphology; while the PD-CRS frontal-subcortical scores presented positive correlations with CTh in the transverse temporal, medial orbitofrontal, superior temporal, precuneus, fusiform, and supramarginal regions. Additionally, PD-CRS subtests for Semantic and Alternating verbal fluency were linked to CTh changes in orbitofrontal, temporal, fusiform, insula, and precentral regions. Conclusion: PD-CRS performance mirrors neuroanatomical changes across extensive fronto-temporo-parietal areas, covering both lateral and medial cortical surfaces, in PD patients without dementia. The observed changes in CVol and CTh associated with this cognitive screening tool suggest their potential as surrogate markers for cognitive decline in PD. These findings warrant further exploration and validation in multicenter studies involving independent patient cohorts. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer JK declared a past co-authorship with the authors PB, DP and TG to the handling editor. (Copyright © 2024 Brandão, Pereira, Grippe, Bispo, Maluf, Titze-de-Almeida, de Almeida e Castro, Munhoz, Tavares and Cardoso.) |
Databáze: | MEDLINE |
Externí odkaz: |